Literature DB >> 17970872

Inflammatory bowel disease: progress and current concepts of etiopathogenesis.

Franco Scaldaferri1, Claudio Fiocchi.   

Abstract

Over the past few years, none of the numerous conditions that are grouped under the broad designation of 'chronic inflammatory or autoimmune disorders' has undergone as much scientific and clinical progress as the two main forms of inflammatory bowel disease (IBD), Crohn's disease (CD) and ulcerative colitis (UC). Progress has occurred in all major areas relevant to IBD pathogenesis, which include the external environment, genetics, microbial factors, and the immune system. This review presents an update on the specific major advances that have occurred in each of these four areas, briefly discusses the therapeutic implications of the observed progress, and points out the additional work that needs to be accomplished in the next few years to reach a full understanding of IBD etiopathogenesis.

Entities:  

Mesh:

Year:  2007        PMID: 17970872     DOI: 10.1111/j.1751-2980.2007.00310.x

Source DB:  PubMed          Journal:  J Dig Dis        ISSN: 1751-2972            Impact factor:   2.325


  42 in total

Review 1.  Intestinal epithelial cells in inflammatory bowel diseases.

Authors:  Giulia Roda; Alessandro Sartini; Elisabetta Zambon; Andrea Calafiore; Margherita Marocchi; Alessandra Caponi; Andrea Belluzzi; Enrico Roda
Journal:  World J Gastroenterol       Date:  2010-09-14       Impact factor: 5.742

Review 2.  A review of the efficacy of traditional Iranian medicine for inflammatory bowel disease.

Authors:  Roja Rahimi; Mohammad Reza Shams-Ardekani; Mohammad Abdollahi
Journal:  World J Gastroenterol       Date:  2010-09-28       Impact factor: 5.742

3.  Influence of sublethal total-body irradiation on immune cell populations in the intestinal mucosa.

Authors:  Sarita Garg; Marjan Boerma; Junru Wang; Qiang Fu; David S Loose; K Sree Kumar; Martin Hauer-Jensen
Journal:  Radiat Res       Date:  2010-04       Impact factor: 2.841

Review 4.  New therapeutic strategies targeting transmembrane signal transduction in the immune system.

Authors:  Alexander B Sigalov
Journal:  Cell Adh Migr       Date:  2010-04-24       Impact factor: 3.405

5.  Comparison between clinical and radiological evaluation before and after medical therapy in patients with Crohn's disease: new prospective roles of CT enterography.

Authors:  Laura Maria Minordi; Franco Scaldaferri; Luigi Larosa; Rosa Marra; Francesco Giordano; Lucrezia Laterza; Iolanda Scoleri; Andrea Poscia; Viviana Gerardi; Giovanni Bruno; Eleonora Gaetani; Antonio Gasbarrini; Amorino Vecchioli; Lorenzo Bonomo
Journal:  Radiol Med       Date:  2014-12-02       Impact factor: 3.469

Review 6.  The genetic predisposition and the interplay of host genetics and gut microbiome in Crohn disease.

Authors:  Hu Jianzhong
Journal:  Clin Lab Med       Date:  2014-09-15       Impact factor: 1.935

Review 7.  Are we giving azathioprine too late? The case for early immunomodulation in inflammatory bowel disease.

Authors:  María Josefina Etchevers; Montserrat Aceituno; Miquel Sans
Journal:  World J Gastroenterol       Date:  2008-09-28       Impact factor: 5.742

8.  Contribution of bone marrow-derived cells to the pro-inflammatory effects of protease-activated receptor-2 in colitis.

Authors:  Eric Hyun; Patricia Andrade-Gordon; Martin Steinhoff; Paul L Beck; Nathalie Vergnolle
Journal:  Inflamm Res       Date:  2010-03-26       Impact factor: 4.575

9.  Association of MYO9B gene polymorphisms with inflammatory bowel disease in Chinese Han population.

Authors:  Jing Hu; Qiao Mei; Jian Huang; Nai-Zhong Hu; Xiao-Chang Liu; Jian-Ming Xu
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

10.  Detection of galectin-3 in patients with inflammatory bowel diseases: new serum marker of active forms of IBD?

Authors:  Lenka Frol'ová; Karel Smetana; Dana Borovská; Andrea Kitanovicová; Klára Klimesová; Ivana Janatková; Karin Malícková; Milan Lukás; Pavel Drastich; Zdenek Benes; Ludmila Tucková; Joachim C Manning; Sabine André; Hans-Joachim Gabius; Helena Tlaskalová-Hogenová
Journal:  Inflamm Res       Date:  2009-03-07       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.